Literature DB >> 22981388

The future of induction chemotherapy for head and neck squamous cell carcinoma.

Missak Haigentz, Ezra E W Cohen, Gregory T Wolf, Primož Strojan, Avraham Eisbruch, Alfio Ferlito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22981388     DOI： 10.1016/j.oraloncology.2012.08.009

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  9 in total

1.  Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.

Authors:  Gregory T Wolf; Emily Bellile; Avraham Eisbruch; Susan Urba; Carol R Bradford; Lisa Peterson; Mark E Prince; Theodoros N Teknos; Douglas B Chepeha; Norman D Hogikyan; Scott A McLean; Jeffery Moyer; Jeremy M G Taylor; Francis P Worden
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-04-01       Impact factor: 6.223

Review 2.  AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.

Authors:  Cory D Fulcher; Missak Haigentz; Thomas J Ow
Journal:  Head Neck       Date:  2017-11-24       Impact factor: 3.147

3.  When is chemotherapy in head and neck squamous cell carcinoma not indicated?

Authors:  Missak Haigentz; Jan B Vermorken; Arlene A Forastiere; June Corry; Jonathan J Beitler; Primož Strojan; Dana M Hartl; Juan P Rodrigo; Carol R Bradford; Alessandra Rinaldo; Robert P Takes; William M Mendenhall; Ashok R Shaha; Gregory T Wolf; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-14       Impact factor: 2.503

4.  Induction chemotherapy followed by radiotherapy in patients with cervical lymph node metastases from unknown primary carcinoma.

Authors:  Young Mi Seol; Young Jin Choi; Byung Joo Lee; Soo Geun Wang
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-09-17

5.  Squamous cell carcinoma of unknown primary tumor metastatic to neck nodes: role of elective irradiation.

Authors:  Primož Strojan; Marko Kokalj; Vesna Zadnik; Aleksandar Aničin; Gaber Plavc; Vojislav Didanović; Robert Šifrer; Boštjan Lanišnik
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-30       Impact factor: 2.503

6.  nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma.

Authors:  Douglas Adkins; Jessica Ley; Loren Michel; Tanya M Wildes; Wade Thorstad; Hiram A Gay; Mackenzie Daly; Jason Rich; Randal Paniello; Ravindra Uppaluri; Ryan Jackson; Kathryn Trinkaus; Brian Nussenbaum
Journal:  Oral Oncol       Date:  2016-07-29       Impact factor: 5.337

Review 7.  Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.

Authors:  Remco de Bree; Gregory T Wolf; Bart de Keizer; Iain J Nixon; Dana M Hartl; Arlene A Forastiere; Missak Haigentz; Alessandra Rinaldo; Juan P Rodrigo; Nabil F Saba; Carlos Suárez; Jan B Vermorken; Alfio Ferlito
Journal:  Head Neck       Date:  2017-08-17       Impact factor: 3.147

8.  A Nomogram for Pretreatment Prediction of Response to Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma.

Authors:  Baoliang Guo; Fusheng Ouyang; Lizhu Ouyang; Xiyi Huang; Haixiong Chen; Tiandi Guo; Shao-Min Yang; Wei Meng; Ziwei Liu; Cuiru Zhou; Qiu-Gen Hu
Journal:  Front Oncol       Date:  2020-12-11       Impact factor: 6.244

9.  Comparisons of histological features among primary oral squamous cell carcinomas before and after adjuvant chemotherapy and their lymph node metastatic cancer lesions after adjuvant chemotherapy.

Authors:  Feng-Chou Cheng; Ling-Hsia Wang; Yi-Ping Wang; Julia Yu-Fong Chang; Chun-Pin Chiang
Journal:  J Dent Sci       Date:  2021-08-21       Impact factor: 2.080
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.